nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—EGFR—sarcoma	0.493	1	CbGaD
Lapatinib—CYP3A4—Thiotepa—sarcoma	0.0251	0.141	CbGbCtD
Lapatinib—ABCB1—Dactinomycin—sarcoma	0.0201	0.113	CbGbCtD
Lapatinib—CYP3A5—Vincristine—sarcoma	0.019	0.107	CbGbCtD
Lapatinib—ABCB1—Mitoxantrone—sarcoma	0.018	0.101	CbGbCtD
Lapatinib—CYP3A5—Etoposide—sarcoma	0.0174	0.0982	CbGbCtD
Lapatinib—CYP2C8—Etoposide—sarcoma	0.0168	0.0944	CbGbCtD
Lapatinib—ABCB1—Vincristine—sarcoma	0.0124	0.0698	CbGbCtD
Lapatinib—ABCB1—Etoposide—sarcoma	0.0113	0.0639	CbGbCtD
Lapatinib—CYP3A4—Mitoxantrone—sarcoma	0.0108	0.0607	CbGbCtD
Lapatinib—ABCB1—Doxorubicin—sarcoma	0.00774	0.0436	CbGbCtD
Lapatinib—CYP3A4—Vincristine—sarcoma	0.00742	0.0418	CbGbCtD
Lapatinib—CYP3A4—Etoposide—sarcoma	0.0068	0.0383	CbGbCtD
Lapatinib—CYP3A4—Doxorubicin—sarcoma	0.00464	0.0261	CbGbCtD
Lapatinib—PIK3C2B—mammary gland—sarcoma	0.00303	0.0458	CbGeAlD
Lapatinib—ERBB2—mammary gland—sarcoma	0.00236	0.0356	CbGeAlD
Lapatinib—ERBB4—mammary gland—sarcoma	0.00236	0.0356	CbGeAlD
Lapatinib—TAP1—myometrium—sarcoma	0.00229	0.0346	CbGeAlD
Lapatinib—PIK3C2B—myometrium—sarcoma	0.00215	0.0325	CbGeAlD
Lapatinib—TAP1—seminal vesicle—sarcoma	0.00207	0.0312	CbGeAlD
Lapatinib—EGFR—mammary gland—sarcoma	0.002	0.0302	CbGeAlD
Lapatinib—PIK3C2B—seminal vesicle—sarcoma	0.00195	0.0293	CbGeAlD
Lapatinib—PIK3C2B—hematopoietic system—sarcoma	0.00185	0.0279	CbGeAlD
Lapatinib—Gefitinib—EGFR—sarcoma	0.00179	1	CrCbGaD
Lapatinib—ERBB2—embryo—sarcoma	0.00161	0.0243	CbGeAlD
Lapatinib—ERBB4—embryo—sarcoma	0.00161	0.0243	CbGeAlD
Lapatinib—PI4KB—myometrium—sarcoma	0.00157	0.0237	CbGeAlD
Lapatinib—TAP1—cardiac atrium—sarcoma	0.0015	0.0225	CbGeAlD
Lapatinib—ERBB2—hematopoietic system—sarcoma	0.00144	0.0217	CbGeAlD
Lapatinib—PI4KB—seminal vesicle—sarcoma	0.00142	0.0214	CbGeAlD
Lapatinib—PIK3C2B—cardiac atrium—sarcoma	0.0014	0.0212	CbGeAlD
Lapatinib—ERBB2—connective tissue—sarcoma	0.00138	0.0209	CbGeAlD
Lapatinib—TAP1—tendon—sarcoma	0.0013	0.0197	CbGeAlD
Lapatinib—ERBB2—smooth muscle tissue—sarcoma	0.00127	0.0191	CbGeAlD
Lapatinib—TAP1—bone marrow—sarcoma	0.00126	0.019	CbGeAlD
Lapatinib—ERBB2—skin of body—sarcoma	0.00125	0.0189	CbGeAlD
Lapatinib—PIK3C2B—tendon—sarcoma	0.00122	0.0185	CbGeAlD
Lapatinib—PI4KB—smooth muscle tissue—sarcoma	0.00119	0.0179	CbGeAlD
Lapatinib—PIK3C2B—bone marrow—sarcoma	0.00119	0.0179	CbGeAlD
Lapatinib—PIK3C2B—Vindesine—Vincristine—sarcoma	0.00116	0.268	CbGdCrCtD
Lapatinib—ERBB4—cardiac atrium—sarcoma	0.00109	0.0165	CbGeAlD
Lapatinib—ERBB2—uterus—sarcoma	0.00109	0.0164	CbGeAlD
Lapatinib—TAP1—testis—sarcoma	0.00108	0.0163	CbGeAlD
Lapatinib—PI4KB—cardiac atrium—sarcoma	0.00102	0.0154	CbGeAlD
Lapatinib—TAP1—liver—sarcoma	0.00102	0.0154	CbGeAlD
Lapatinib—PI4KB—uterus—sarcoma	0.00102	0.0153	CbGeAlD
Lapatinib—PIK3C2B—testis—sarcoma	0.00101	0.0153	CbGeAlD
Lapatinib—ERBB2—lymphoid tissue—sarcoma	0.00101	0.0153	CbGeAlD
Lapatinib—PIK3C2B—liver—sarcoma	0.000958	0.0144	CbGeAlD
Lapatinib—ERBB4—tendon—sarcoma	0.000952	0.0144	CbGeAlD
Lapatinib—EGFR—uterus—sarcoma	0.000921	0.0139	CbGeAlD
Lapatinib—PI4KB—tendon—sarcoma	0.000891	0.0134	CbGeAlD
Lapatinib—PI4KB—bone marrow—sarcoma	0.000863	0.013	CbGeAlD
Lapatinib—ERBB2—testis—sarcoma	0.000788	0.0119	CbGeAlD
Lapatinib—ERBB4—testis—sarcoma	0.000788	0.0119	CbGeAlD
Lapatinib—TAP1—lymph node—sarcoma	0.000782	0.0118	CbGeAlD
Lapatinib—ERBB2—liver—sarcoma	0.000745	0.0112	CbGeAlD
Lapatinib—PI4KB—testis—sarcoma	0.000738	0.0111	CbGeAlD
Lapatinib—PIK3C2B—Vinorelbine—Vincristine—sarcoma	0.000735	0.169	CbGdCrCtD
Lapatinib—PIK3C2B—lymph node—sarcoma	0.000734	0.0111	CbGeAlD
Lapatinib—PIK3C2B—Podofilox—Etoposide—sarcoma	0.000734	0.169	CbGdCrCtD
Lapatinib—PI4KB—liver—sarcoma	0.000698	0.0105	CbGeAlD
Lapatinib—EGFR—testis—sarcoma	0.000668	0.0101	CbGeAlD
Lapatinib—CYP2C8—mammary gland—sarcoma	0.000641	0.00967	CbGeAlD
Lapatinib—EGFR—liver—sarcoma	0.000632	0.00952	CbGeAlD
Lapatinib—ERBB2—Podofilox—Etoposide—sarcoma	0.000605	0.139	CbGdCrCtD
Lapatinib—ERBB2—lymph node—sarcoma	0.000571	0.00861	CbGeAlD
Lapatinib—PI4KB—lymph node—sarcoma	0.000535	0.00807	CbGeAlD
Lapatinib—PIK3C2B—Vinblastine—Vincristine—sarcoma	0.000505	0.116	CbGdCrCtD
Lapatinib—EGFR—lymph node—sarcoma	0.000484	0.0073	CbGeAlD
Lapatinib—CYP2C19—hematopoietic system—sarcoma	0.000448	0.00675	CbGeAlD
Lapatinib—CYP2C8—hematopoietic system—sarcoma	0.000391	0.00589	CbGeAlD
Lapatinib—CYP3A5—hematopoietic system—sarcoma	0.000353	0.00532	CbGeAlD
Lapatinib—Neutropenia—Etoposide—sarcoma	0.00032	0.00277	CcSEcCtD
Lapatinib—ERBB2—Doxorubicin—Epirubicin—sarcoma	0.000315	0.0725	CbGdCrCtD
Lapatinib—Cardiac disorder—Vincristine—sarcoma	0.000314	0.00271	CcSEcCtD
Lapatinib—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.000311	0.00269	CcSEcCtD
Lapatinib—Pneumonia—Etoposide—sarcoma	0.000307	0.00265	CcSEcCtD
Lapatinib—Anaemia—Thiotepa—sarcoma	0.000307	0.00265	CcSEcCtD
Lapatinib—Angiopathy—Vincristine—sarcoma	0.000307	0.00265	CcSEcCtD
Lapatinib—Infestation NOS—Etoposide—sarcoma	0.000305	0.00264	CcSEcCtD
Lapatinib—Infestation—Etoposide—sarcoma	0.000305	0.00264	CcSEcCtD
Lapatinib—Mediastinal disorder—Vincristine—sarcoma	0.000305	0.00263	CcSEcCtD
Lapatinib—Anaemia—Dactinomycin—sarcoma	0.000304	0.00263	CcSEcCtD
Lapatinib—Blood bilirubin increased—Doxorubicin—sarcoma	0.000299	0.00259	CcSEcCtD
Lapatinib—Neuropathy peripheral—Etoposide—sarcoma	0.000299	0.00258	CcSEcCtD
Lapatinib—Alopecia—Vincristine—sarcoma	0.000299	0.00258	CcSEcCtD
Lapatinib—Stomatitis—Etoposide—sarcoma	0.000297	0.00257	CcSEcCtD
Lapatinib—Leukopenia—Thiotepa—sarcoma	0.000297	0.00257	CcSEcCtD
Lapatinib—Mental disorder—Vincristine—sarcoma	0.000296	0.00256	CcSEcCtD
Lapatinib—Leukopenia—Dactinomycin—sarcoma	0.000295	0.00255	CcSEcCtD
Lapatinib—ERBB2—Epirubicin—Doxorubicin—sarcoma	0.000292	0.0671	CbGdCrCtD
Lapatinib—Alopecia—Mitoxantrone—sarcoma	0.000291	0.00251	CcSEcCtD
Lapatinib—Cough—Thiotepa—sarcoma	0.00029	0.0025	CcSEcCtD
Lapatinib—Hepatobiliary disease—Etoposide—sarcoma	0.000288	0.00249	CcSEcCtD
Lapatinib—Back pain—Vincristine—sarcoma	0.000285	0.00246	CcSEcCtD
Lapatinib—Arthralgia—Thiotepa—sarcoma	0.000282	0.00244	CcSEcCtD
Lapatinib—Myalgia—Thiotepa—sarcoma	0.000282	0.00244	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000281	0.00243	CcSEcCtD
Lapatinib—Myalgia—Dactinomycin—sarcoma	0.00028	0.00242	CcSEcCtD
Lapatinib—Back pain—Mitoxantrone—sarcoma	0.000277	0.0024	CcSEcCtD
Lapatinib—Anaemia—Vincristine—sarcoma	0.000272	0.00235	CcSEcCtD
Lapatinib—Infection—Thiotepa—sarcoma	0.000269	0.00233	CcSEcCtD
Lapatinib—Infection—Dactinomycin—sarcoma	0.000267	0.00231	CcSEcCtD
Lapatinib—Nervous system disorder—Thiotepa—sarcoma	0.000266	0.0023	CcSEcCtD
Lapatinib—Anaemia—Mitoxantrone—sarcoma	0.000265	0.00229	CcSEcCtD
Lapatinib—CYP3A4—hematopoietic system—sarcoma	0.000265	0.00399	CbGeAlD
Lapatinib—Leukopenia—Vincristine—sarcoma	0.000263	0.00228	CcSEcCtD
Lapatinib—Skin disorder—Thiotepa—sarcoma	0.000263	0.00227	CcSEcCtD
Lapatinib—Anorexia—Thiotepa—sarcoma	0.000258	0.00223	CcSEcCtD
Lapatinib—Leukopenia—Mitoxantrone—sarcoma	0.000256	0.00222	CcSEcCtD
Lapatinib—Anorexia—Dactinomycin—sarcoma	0.000256	0.00222	CcSEcCtD
Lapatinib—Cardiac disorder—Etoposide—sarcoma	0.000254	0.0022	CcSEcCtD
Lapatinib—Myalgia—Vincristine—sarcoma	0.00025	0.00217	CcSEcCtD
Lapatinib—Cough—Mitoxantrone—sarcoma	0.00025	0.00216	CcSEcCtD
Lapatinib—Angiopathy—Etoposide—sarcoma	0.000248	0.00215	CcSEcCtD
Lapatinib—Immune system disorder—Etoposide—sarcoma	0.000247	0.00214	CcSEcCtD
Lapatinib—Mediastinal disorder—Etoposide—sarcoma	0.000247	0.00213	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000247	0.00213	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000245	0.00212	CcSEcCtD
Lapatinib—Myalgia—Mitoxantrone—sarcoma	0.000244	0.00211	CcSEcCtD
Lapatinib—Arthralgia—Mitoxantrone—sarcoma	0.000244	0.00211	CcSEcCtD
Lapatinib—Alopecia—Etoposide—sarcoma	0.000242	0.00209	CcSEcCtD
Lapatinib—Renal failure acute—Epirubicin—sarcoma	0.00024	0.00208	CcSEcCtD
Lapatinib—Anaphylactic shock—Vincristine—sarcoma	0.00024	0.00208	CcSEcCtD
Lapatinib—Infection—Vincristine—sarcoma	0.000239	0.00206	CcSEcCtD
Lapatinib—Dyspepsia—Thiotepa—sarcoma	0.000238	0.00206	CcSEcCtD
Lapatinib—Hot flush—Epirubicin—sarcoma	0.000237	0.00205	CcSEcCtD
Lapatinib—Nervous system disorder—Vincristine—sarcoma	0.000235	0.00204	CcSEcCtD
Lapatinib—Decreased appetite—Thiotepa—sarcoma	0.000235	0.00204	CcSEcCtD
Lapatinib—Menopausal symptoms—Epirubicin—sarcoma	0.000235	0.00203	CcSEcCtD
Lapatinib—Anaphylactic shock—Mitoxantrone—sarcoma	0.000234	0.00202	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Thiotepa—sarcoma	0.000234	0.00202	CcSEcCtD
Lapatinib—Decreased appetite—Dactinomycin—sarcoma	0.000234	0.00202	CcSEcCtD
Lapatinib—Fatigue—Thiotepa—sarcoma	0.000233	0.00202	CcSEcCtD
Lapatinib—Infection—Mitoxantrone—sarcoma	0.000232	0.00201	CcSEcCtD
Lapatinib—CYP2C19—liver—sarcoma	0.000232	0.0035	CbGeAlD
Lapatinib—Fatigue—Dactinomycin—sarcoma	0.000232	0.002	CcSEcCtD
Lapatinib—Constipation—Thiotepa—sarcoma	0.000232	0.002	CcSEcCtD
Lapatinib—Back pain—Etoposide—sarcoma	0.000231	0.00199	CcSEcCtD
Lapatinib—Anorexia—Vincristine—sarcoma	0.000229	0.00198	CcSEcCtD
Lapatinib—Cardiac failure—Epirubicin—sarcoma	0.000227	0.00197	CcSEcCtD
Lapatinib—Skin disorder—Mitoxantrone—sarcoma	0.000227	0.00196	CcSEcCtD
Lapatinib—Anorexia—Mitoxantrone—sarcoma	0.000223	0.00193	CcSEcCtD
Lapatinib—Renal failure acute—Doxorubicin—sarcoma	0.000222	0.00192	CcSEcCtD
Lapatinib—Pain in extremity—Epirubicin—sarcoma	0.000222	0.00192	CcSEcCtD
Lapatinib—Gastrointestinal pain—Thiotepa—sarcoma	0.000221	0.00191	CcSEcCtD
Lapatinib—Anaemia—Etoposide—sarcoma	0.00022	0.0019	CcSEcCtD
Lapatinib—Gastrointestinal pain—Dactinomycin—sarcoma	0.00022	0.0019	CcSEcCtD
Lapatinib—Hot flush—Doxorubicin—sarcoma	0.000219	0.0019	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Vincristine—sarcoma	0.000219	0.00189	CcSEcCtD
Lapatinib—ABCB1—myometrium—sarcoma	0.000218	0.00329	CbGeAlD
Lapatinib—Menopausal symptoms—Doxorubicin—sarcoma	0.000218	0.00188	CcSEcCtD
Lapatinib—Insomnia—Vincristine—sarcoma	0.000217	0.00188	CcSEcCtD
Lapatinib—CYP2C8—testis—sarcoma	0.000214	0.00323	CbGeAlD
Lapatinib—Abdominal pain—Thiotepa—sarcoma	0.000214	0.00185	CcSEcCtD
Lapatinib—Leukopenia—Etoposide—sarcoma	0.000213	0.00184	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000213	0.00184	CcSEcCtD
Lapatinib—Abdominal pain—Dactinomycin—sarcoma	0.000212	0.00184	CcSEcCtD
Lapatinib—Cardiac failure—Doxorubicin—sarcoma	0.00021	0.00182	CcSEcCtD
Lapatinib—ABCB1—embryo—sarcoma	0.00021	0.00316	CbGeAlD
Lapatinib—Decreased appetite—Vincristine—sarcoma	0.000209	0.0018	CcSEcCtD
Lapatinib—Dyspnoea—Mitoxantrone—sarcoma	0.000208	0.0018	CcSEcCtD
Lapatinib—Cough—Etoposide—sarcoma	0.000208	0.0018	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Vincristine—sarcoma	0.000207	0.00179	CcSEcCtD
Lapatinib—Fatigue—Vincristine—sarcoma	0.000207	0.00179	CcSEcCtD
Lapatinib—Dehydration—Epirubicin—sarcoma	0.000206	0.00178	CcSEcCtD
Lapatinib—Dyspepsia—Mitoxantrone—sarcoma	0.000206	0.00178	CcSEcCtD
Lapatinib—Constipation—Vincristine—sarcoma	0.000205	0.00178	CcSEcCtD
Lapatinib—Pain in extremity—Doxorubicin—sarcoma	0.000205	0.00177	CcSEcCtD
Lapatinib—Dry skin—Epirubicin—sarcoma	0.000203	0.00176	CcSEcCtD
Lapatinib—Decreased appetite—Mitoxantrone—sarcoma	0.000203	0.00176	CcSEcCtD
Lapatinib—CYP2C8—liver—sarcoma	0.000202	0.00305	CbGeAlD
Lapatinib—Fatigue—Mitoxantrone—sarcoma	0.000202	0.00174	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000201	0.00174	CcSEcCtD
Lapatinib—Constipation—Mitoxantrone—sarcoma	0.0002	0.00173	CcSEcCtD
Lapatinib—Hypersensitivity—Thiotepa—sarcoma	0.000199	0.00173	CcSEcCtD
Lapatinib—Hypersensitivity—Dactinomycin—sarcoma	0.000198	0.00171	CcSEcCtD
Lapatinib—ABCB1—seminal vesicle—sarcoma	0.000197	0.00297	CbGeAlD
Lapatinib—Gastrointestinal pain—Vincristine—sarcoma	0.000196	0.0017	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000196	0.00169	CcSEcCtD
Lapatinib—Anaphylactic shock—Etoposide—sarcoma	0.000194	0.00168	CcSEcCtD
Lapatinib—Asthenia—Thiotepa—sarcoma	0.000194	0.00168	CcSEcCtD
Lapatinib—Infection—Etoposide—sarcoma	0.000193	0.00167	CcSEcCtD
Lapatinib—Asthenia—Dactinomycin—sarcoma	0.000193	0.00167	CcSEcCtD
Lapatinib—Pruritus—Thiotepa—sarcoma	0.000192	0.00166	CcSEcCtD
Lapatinib—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000191	0.00165	CcSEcCtD
Lapatinib—Dehydration—Doxorubicin—sarcoma	0.000191	0.00165	CcSEcCtD
Lapatinib—Abdominal pain—Vincristine—sarcoma	0.00019	0.00164	CcSEcCtD
Lapatinib—Skin disorder—Etoposide—sarcoma	0.000189	0.00163	CcSEcCtD
Lapatinib—Dry skin—Doxorubicin—sarcoma	0.000188	0.00163	CcSEcCtD
Lapatinib—ABCB1—hematopoietic system—sarcoma	0.000187	0.00283	CbGeAlD
Lapatinib—Anorexia—Etoposide—sarcoma	0.000185	0.0016	CcSEcCtD
Lapatinib—Diarrhoea—Thiotepa—sarcoma	0.000185	0.0016	CcSEcCtD
Lapatinib—Abdominal pain—Mitoxantrone—sarcoma	0.000185	0.0016	CcSEcCtD
Lapatinib—Diarrhoea—Dactinomycin—sarcoma	0.000184	0.00159	CcSEcCtD
Lapatinib—CYP3A5—liver—sarcoma	0.000183	0.00276	CbGeAlD
Lapatinib—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000181	0.00157	CcSEcCtD
Lapatinib—Neutropenia—Epirubicin—sarcoma	0.000179	0.00155	CcSEcCtD
Lapatinib—Hypersensitivity—Vincristine—sarcoma	0.000177	0.00153	CcSEcCtD
Lapatinib—Dyspnoea—Etoposide—sarcoma	0.000173	0.0015	CcSEcCtD
Lapatinib—Hypersensitivity—Mitoxantrone—sarcoma	0.000172	0.00149	CcSEcCtD
Lapatinib—Asthenia—Vincristine—sarcoma	0.000172	0.00149	CcSEcCtD
Lapatinib—Vomiting—Thiotepa—sarcoma	0.000172	0.00149	CcSEcCtD
Lapatinib—Pneumonia—Epirubicin—sarcoma	0.000172	0.00149	CcSEcCtD
Lapatinib—Infestation—Epirubicin—sarcoma	0.000171	0.00148	CcSEcCtD
Lapatinib—Infestation NOS—Epirubicin—sarcoma	0.000171	0.00148	CcSEcCtD
Lapatinib—Vomiting—Dactinomycin—sarcoma	0.000171	0.00148	CcSEcCtD
Lapatinib—Rash—Thiotepa—sarcoma	0.000171	0.00148	CcSEcCtD
Lapatinib—Dermatitis—Thiotepa—sarcoma	0.000171	0.00147	CcSEcCtD
Lapatinib—Headache—Thiotepa—sarcoma	0.00017	0.00147	CcSEcCtD
Lapatinib—Rash—Dactinomycin—sarcoma	0.000169	0.00147	CcSEcCtD
Lapatinib—Decreased appetite—Etoposide—sarcoma	0.000169	0.00146	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Etoposide—sarcoma	0.000168	0.00145	CcSEcCtD
Lapatinib—Asthenia—Mitoxantrone—sarcoma	0.000168	0.00145	CcSEcCtD
Lapatinib—Fatigue—Etoposide—sarcoma	0.000168	0.00145	CcSEcCtD
Lapatinib—Neuropathy peripheral—Epirubicin—sarcoma	0.000168	0.00145	CcSEcCtD
Lapatinib—Stomatitis—Epirubicin—sarcoma	0.000167	0.00144	CcSEcCtD
Lapatinib—Constipation—Etoposide—sarcoma	0.000166	0.00144	CcSEcCtD
Lapatinib—Neutropenia—Doxorubicin—sarcoma	0.000166	0.00143	CcSEcCtD
Lapatinib—Diarrhoea—Vincristine—sarcoma	0.000164	0.00142	CcSEcCtD
Lapatinib—Hepatobiliary disease—Epirubicin—sarcoma	0.000162	0.0014	CcSEcCtD
Lapatinib—Epistaxis—Epirubicin—sarcoma	0.000161	0.00139	CcSEcCtD
Lapatinib—Nausea—Thiotepa—sarcoma	0.000161	0.00139	CcSEcCtD
Lapatinib—Diarrhoea—Mitoxantrone—sarcoma	0.00016	0.00138	CcSEcCtD
Lapatinib—Nausea—Dactinomycin—sarcoma	0.00016	0.00138	CcSEcCtD
Lapatinib—Pneumonia—Doxorubicin—sarcoma	0.000159	0.00138	CcSEcCtD
Lapatinib—Gastrointestinal pain—Etoposide—sarcoma	0.000159	0.00138	CcSEcCtD
Lapatinib—Infestation NOS—Doxorubicin—sarcoma	0.000158	0.00137	CcSEcCtD
Lapatinib—Infestation—Doxorubicin—sarcoma	0.000158	0.00137	CcSEcCtD
Lapatinib—Neuropathy peripheral—Doxorubicin—sarcoma	0.000155	0.00134	CcSEcCtD
Lapatinib—Stomatitis—Doxorubicin—sarcoma	0.000154	0.00133	CcSEcCtD
Lapatinib—Abdominal pain—Etoposide—sarcoma	0.000154	0.00133	CcSEcCtD
Lapatinib—Vomiting—Vincristine—sarcoma	0.000153	0.00132	CcSEcCtD
Lapatinib—Rash—Vincristine—sarcoma	0.000151	0.00131	CcSEcCtD
Lapatinib—Dermatitis—Vincristine—sarcoma	0.000151	0.00131	CcSEcCtD
Lapatinib—Connective tissue disorder—Epirubicin—sarcoma	0.000151	0.0013	CcSEcCtD
Lapatinib—Headache—Vincristine—sarcoma	0.00015	0.0013	CcSEcCtD
Lapatinib—Hepatobiliary disease—Doxorubicin—sarcoma	0.00015	0.00129	CcSEcCtD
Lapatinib—Epistaxis—Doxorubicin—sarcoma	0.000149	0.00129	CcSEcCtD
Lapatinib—Vomiting—Mitoxantrone—sarcoma	0.000149	0.00129	CcSEcCtD
Lapatinib—Rash—Mitoxantrone—sarcoma	0.000147	0.00127	CcSEcCtD
Lapatinib—Dermatitis—Mitoxantrone—sarcoma	0.000147	0.00127	CcSEcCtD
Lapatinib—Headache—Mitoxantrone—sarcoma	0.000146	0.00127	CcSEcCtD
Lapatinib—Hypersensitivity—Etoposide—sarcoma	0.000143	0.00124	CcSEcCtD
Lapatinib—Nausea—Vincristine—sarcoma	0.000143	0.00123	CcSEcCtD
Lapatinib—Cardiac disorder—Epirubicin—sarcoma	0.000142	0.00123	CcSEcCtD
Lapatinib—ABCB1—uterus—sarcoma	0.000141	0.00213	CbGeAlD
Lapatinib—Asthenia—Etoposide—sarcoma	0.00014	0.00121	CcSEcCtD
Lapatinib—Connective tissue disorder—Doxorubicin—sarcoma	0.00014	0.00121	CcSEcCtD
Lapatinib—Angiopathy—Epirubicin—sarcoma	0.000139	0.0012	CcSEcCtD
Lapatinib—Nausea—Mitoxantrone—sarcoma	0.000139	0.0012	CcSEcCtD
Lapatinib—Immune system disorder—Epirubicin—sarcoma	0.000139	0.0012	CcSEcCtD
Lapatinib—Mediastinal disorder—Epirubicin—sarcoma	0.000138	0.0012	CcSEcCtD
Lapatinib—Pruritus—Etoposide—sarcoma	0.000138	0.00119	CcSEcCtD
Lapatinib—CYP3A4—liver—sarcoma	0.000137	0.00207	CbGeAlD
Lapatinib—Alopecia—Epirubicin—sarcoma	0.000136	0.00117	CcSEcCtD
Lapatinib—Mental disorder—Epirubicin—sarcoma	0.000134	0.00116	CcSEcCtD
Lapatinib—Malnutrition—Epirubicin—sarcoma	0.000134	0.00116	CcSEcCtD
Lapatinib—Diarrhoea—Etoposide—sarcoma	0.000133	0.00115	CcSEcCtD
Lapatinib—ABCB1—lymphoid tissue—sarcoma	0.000132	0.00199	CbGeAlD
Lapatinib—Cardiac disorder—Doxorubicin—sarcoma	0.000132	0.00114	CcSEcCtD
Lapatinib—Back pain—Epirubicin—sarcoma	0.000129	0.00112	CcSEcCtD
Lapatinib—Angiopathy—Doxorubicin—sarcoma	0.000129	0.00111	CcSEcCtD
Lapatinib—Immune system disorder—Doxorubicin—sarcoma	0.000128	0.00111	CcSEcCtD
Lapatinib—Mediastinal disorder—Doxorubicin—sarcoma	0.000128	0.00111	CcSEcCtD
Lapatinib—Alopecia—Doxorubicin—sarcoma	0.000125	0.00109	CcSEcCtD
Lapatinib—Mental disorder—Doxorubicin—sarcoma	0.000124	0.00108	CcSEcCtD
Lapatinib—Vomiting—Etoposide—sarcoma	0.000124	0.00107	CcSEcCtD
Lapatinib—Malnutrition—Doxorubicin—sarcoma	0.000124	0.00107	CcSEcCtD
Lapatinib—Anaemia—Epirubicin—sarcoma	0.000123	0.00107	CcSEcCtD
Lapatinib—Rash—Etoposide—sarcoma	0.000123	0.00106	CcSEcCtD
Lapatinib—Dermatitis—Etoposide—sarcoma	0.000123	0.00106	CcSEcCtD
Lapatinib—Headache—Etoposide—sarcoma	0.000122	0.00105	CcSEcCtD
Lapatinib—ABCB1—bone marrow—sarcoma	0.00012	0.00181	CbGeAlD
Lapatinib—Leukopenia—Epirubicin—sarcoma	0.00012	0.00103	CcSEcCtD
Lapatinib—Back pain—Doxorubicin—sarcoma	0.00012	0.00103	CcSEcCtD
Lapatinib—Palpitations—Epirubicin—sarcoma	0.000118	0.00102	CcSEcCtD
Lapatinib—Cough—Epirubicin—sarcoma	0.000117	0.00101	CcSEcCtD
Lapatinib—Nausea—Etoposide—sarcoma	0.000116	0.000999	CcSEcCtD
Lapatinib—Anaemia—Doxorubicin—sarcoma	0.000114	0.000988	CcSEcCtD
Lapatinib—Myalgia—Epirubicin—sarcoma	0.000114	0.000983	CcSEcCtD
Lapatinib—Arthralgia—Epirubicin—sarcoma	0.000114	0.000983	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000113	0.000977	CcSEcCtD
Lapatinib—Leukopenia—Doxorubicin—sarcoma	0.000111	0.000957	CcSEcCtD
Lapatinib—Palpitations—Doxorubicin—sarcoma	0.000109	0.000945	CcSEcCtD
Lapatinib—Anaphylactic shock—Epirubicin—sarcoma	0.000109	0.000943	CcSEcCtD
Lapatinib—Infection—Epirubicin—sarcoma	0.000108	0.000937	CcSEcCtD
Lapatinib—Cough—Doxorubicin—sarcoma	0.000108	0.000933	CcSEcCtD
Lapatinib—Nervous system disorder—Epirubicin—sarcoma	0.000107	0.000925	CcSEcCtD
Lapatinib—Skin disorder—Epirubicin—sarcoma	0.000106	0.000916	CcSEcCtD
Lapatinib—Arthralgia—Doxorubicin—sarcoma	0.000105	0.00091	CcSEcCtD
Lapatinib—Myalgia—Doxorubicin—sarcoma	0.000105	0.00091	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000105	0.000904	CcSEcCtD
Lapatinib—Anorexia—Epirubicin—sarcoma	0.000104	0.000899	CcSEcCtD
Lapatinib—ABCB1—testis—sarcoma	0.000103	0.00155	CbGeAlD
Lapatinib—Anaphylactic shock—Doxorubicin—sarcoma	0.000101	0.000872	CcSEcCtD
Lapatinib—Infection—Doxorubicin—sarcoma	0.0001	0.000867	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Epirubicin—sarcoma	9.93e-05	0.000859	CcSEcCtD
Lapatinib—Nervous system disorder—Doxorubicin—sarcoma	9.89e-05	0.000855	CcSEcCtD
Lapatinib—Insomnia—Epirubicin—sarcoma	9.86e-05	0.000853	CcSEcCtD
Lapatinib—Skin disorder—Doxorubicin—sarcoma	9.8e-05	0.000847	CcSEcCtD
Lapatinib—Dyspnoea—Epirubicin—sarcoma	9.72e-05	0.000841	CcSEcCtD
Lapatinib—ABCB1—liver—sarcoma	9.71e-05	0.00146	CbGeAlD
Lapatinib—Anorexia—Doxorubicin—sarcoma	9.62e-05	0.000832	CcSEcCtD
Lapatinib—Dyspepsia—Epirubicin—sarcoma	9.6e-05	0.00083	CcSEcCtD
Lapatinib—Decreased appetite—Epirubicin—sarcoma	9.48e-05	0.00082	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Epirubicin—sarcoma	9.41e-05	0.000814	CcSEcCtD
Lapatinib—Fatigue—Epirubicin—sarcoma	9.4e-05	0.000813	CcSEcCtD
Lapatinib—Constipation—Epirubicin—sarcoma	9.32e-05	0.000806	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Doxorubicin—sarcoma	9.19e-05	0.000795	CcSEcCtD
Lapatinib—Insomnia—Doxorubicin—sarcoma	9.12e-05	0.000789	CcSEcCtD
Lapatinib—Dyspnoea—Doxorubicin—sarcoma	8.99e-05	0.000778	CcSEcCtD
Lapatinib—Gastrointestinal pain—Epirubicin—sarcoma	8.92e-05	0.000771	CcSEcCtD
Lapatinib—Dyspepsia—Doxorubicin—sarcoma	8.88e-05	0.000768	CcSEcCtD
Lapatinib—Decreased appetite—Doxorubicin—sarcoma	8.77e-05	0.000758	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Doxorubicin—sarcoma	8.71e-05	0.000753	CcSEcCtD
Lapatinib—Fatigue—Doxorubicin—sarcoma	8.7e-05	0.000752	CcSEcCtD
Lapatinib—Constipation—Doxorubicin—sarcoma	8.63e-05	0.000746	CcSEcCtD
Lapatinib—Abdominal pain—Epirubicin—sarcoma	8.62e-05	0.000745	CcSEcCtD
Lapatinib—Gastrointestinal pain—Doxorubicin—sarcoma	8.25e-05	0.000713	CcSEcCtD
Lapatinib—Hypersensitivity—Epirubicin—sarcoma	8.03e-05	0.000695	CcSEcCtD
Lapatinib—Abdominal pain—Doxorubicin—sarcoma	7.97e-05	0.00069	CcSEcCtD
Lapatinib—Asthenia—Epirubicin—sarcoma	7.82e-05	0.000676	CcSEcCtD
Lapatinib—Pruritus—Epirubicin—sarcoma	7.71e-05	0.000667	CcSEcCtD
Lapatinib—Diarrhoea—Epirubicin—sarcoma	7.46e-05	0.000645	CcSEcCtD
Lapatinib—ABCB1—lymph node—sarcoma	7.44e-05	0.00112	CbGeAlD
Lapatinib—Hypersensitivity—Doxorubicin—sarcoma	7.43e-05	0.000643	CcSEcCtD
Lapatinib—Asthenia—Doxorubicin—sarcoma	7.24e-05	0.000626	CcSEcCtD
Lapatinib—Pruritus—Doxorubicin—sarcoma	7.14e-05	0.000617	CcSEcCtD
Lapatinib—Vomiting—Epirubicin—sarcoma	6.93e-05	0.000599	CcSEcCtD
Lapatinib—Diarrhoea—Doxorubicin—sarcoma	6.9e-05	0.000597	CcSEcCtD
Lapatinib—Rash—Epirubicin—sarcoma	6.87e-05	0.000594	CcSEcCtD
Lapatinib—Dermatitis—Epirubicin—sarcoma	6.87e-05	0.000594	CcSEcCtD
Lapatinib—Headache—Epirubicin—sarcoma	6.83e-05	0.000591	CcSEcCtD
Lapatinib—Nausea—Epirubicin—sarcoma	6.48e-05	0.00056	CcSEcCtD
Lapatinib—Vomiting—Doxorubicin—sarcoma	6.41e-05	0.000555	CcSEcCtD
Lapatinib—Rash—Doxorubicin—sarcoma	6.36e-05	0.00055	CcSEcCtD
Lapatinib—Dermatitis—Doxorubicin—sarcoma	6.35e-05	0.00055	CcSEcCtD
Lapatinib—Headache—Doxorubicin—sarcoma	6.32e-05	0.000546	CcSEcCtD
Lapatinib—Nausea—Doxorubicin—sarcoma	5.99e-05	0.000518	CcSEcCtD
Lapatinib—EGFR—Adaptive Immune System—PDGFRB—sarcoma	2.4e-05	0.000169	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—HRAS—sarcoma	2.39e-05	0.000169	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—SRC—sarcoma	2.38e-05	0.000168	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—PDGFRA—sarcoma	2.36e-05	0.000167	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.35e-05	0.000166	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—KDR—sarcoma	2.34e-05	0.000165	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—NRAS—sarcoma	2.33e-05	0.000164	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—SRC—sarcoma	2.32e-05	0.000164	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—sarcoma	2.31e-05	0.000163	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—KRAS—sarcoma	2.31e-05	0.000163	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—KIT—sarcoma	2.3e-05	0.000162	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—NRAS—sarcoma	2.29e-05	0.000162	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—SRC—sarcoma	2.29e-05	0.000162	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—HRAS—sarcoma	2.29e-05	0.000161	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—HRAS—sarcoma	2.28e-05	0.000161	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—HRAS—sarcoma	2.28e-05	0.000161	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—KRAS—sarcoma	2.27e-05	0.00016	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—HRAS—sarcoma	2.26e-05	0.00016	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—KIT—sarcoma	2.26e-05	0.00016	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—HRAS—sarcoma	2.25e-05	0.000159	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—NRAS—sarcoma	2.24e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Disease—ENO2—sarcoma	2.23e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	2.22e-05	0.000157	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.22e-05	0.000157	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	2.21e-05	0.000156	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—NRAS—sarcoma	2.2e-05	0.000156	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CREB1—sarcoma	2.19e-05	0.000154	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCR4—sarcoma	2.16e-05	0.000152	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CREB1—sarcoma	2.15e-05	0.000152	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	2.13e-05	0.000151	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EGFR—sarcoma	2.12e-05	0.00015	CbGpPWpGaD
Lapatinib—ERBB2—Disease—KIT—sarcoma	2.12e-05	0.00015	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—HRAS—sarcoma	2.12e-05	0.00015	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	2.12e-05	0.00015	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—HRAS—sarcoma	2.12e-05	0.00015	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—HRAS—sarcoma	2.1e-05	0.000148	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PTPRC—sarcoma	2.1e-05	0.000148	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EGFR—sarcoma	2.09e-05	0.000148	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KIT—sarcoma	2.09e-05	0.000147	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.09e-05	0.000147	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—HRAS—sarcoma	2.08e-05	0.000147	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—HRAS—sarcoma	2.07e-05	0.000146	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CREB1—sarcoma	2.05e-05	0.000145	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PLCG1—sarcoma	2.05e-05	0.000145	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—SRC—sarcoma	2.05e-05	0.000145	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF1R—sarcoma	2.05e-05	0.000145	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—EGFR—sarcoma	2.04e-05	0.000144	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CREB1—sarcoma	2.02e-05	0.000142	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF1R—sarcoma	2.02e-05	0.000142	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—EGFR—sarcoma	2.01e-05	0.000142	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—KRAS—sarcoma	2e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—HRAS—sarcoma	2e-05	0.000141	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TLE1—sarcoma	2e-05	0.000141	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CREB1—sarcoma	1.99e-05	0.00014	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—KRAS—sarcoma	1.97e-05	0.000139	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—NRAS—sarcoma	1.97e-05	0.000139	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—HRAS—sarcoma	1.96e-05	0.000139	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ATF1—sarcoma	1.95e-05	0.000138	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FOXO1—sarcoma	1.95e-05	0.000138	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PDGFRB—sarcoma	1.95e-05	0.000137	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—HRAS—sarcoma	1.93e-05	0.000136	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—KRAS—sarcoma	1.92e-05	0.000136	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FOXO1—sarcoma	1.92e-05	0.000136	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PDGFRB—sarcoma	1.92e-05	0.000135	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PDGFRA—sarcoma	1.91e-05	0.000135	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP2—sarcoma	1.91e-05	0.000135	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KIT—sarcoma	1.91e-05	0.000135	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—KRAS—sarcoma	1.9e-05	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Disease—PLCG1—sarcoma	1.9e-05	0.000134	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PDGFRA—sarcoma	1.89e-05	0.000133	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	1.88e-05	0.000133	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—SRC—sarcoma	1.86e-05	0.000131	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.83e-05	0.00013	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KIT—sarcoma	1.83e-05	0.000129	CbGpPWpGaD
Lapatinib—EGFR—Disease—CXCR4—sarcoma	1.82e-05	0.000129	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	1.81e-05	0.000128	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CREB1—sarcoma	1.81e-05	0.000128	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—VEGFA—sarcoma	1.81e-05	0.000128	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—MDM2—sarcoma	1.81e-05	0.000128	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—NRAS—sarcoma	1.79e-05	0.000126	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—MDM2—sarcoma	1.78e-05	0.000126	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CREB1—sarcoma	1.74e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—HRAS—sarcoma	1.7e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—KRAS—sarcoma	1.7e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFC—sarcoma	1.69e-05	0.000119	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HRAS—sarcoma	1.68e-05	0.000118	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MDM2—sarcoma	1.67e-05	0.000118	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MDM2—sarcoma	1.64e-05	0.000116	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HRAS—sarcoma	1.64e-05	0.000116	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2—sarcoma	1.62e-05	0.000114	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KDR—sarcoma	1.61e-05	0.000114	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HRAS—sarcoma	1.61e-05	0.000114	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.6e-05	0.000113	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.59e-05	0.000113	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2—sarcoma	1.59e-05	0.000112	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KDR—sarcoma	1.59e-05	0.000112	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.58e-05	0.000112	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—JUN—sarcoma	1.57e-05	0.000111	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CTNNB1—sarcoma	1.56e-05	0.00011	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—JUN—sarcoma	1.55e-05	0.000109	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—KRAS—sarcoma	1.54e-05	0.000109	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CTNNB1—sarcoma	1.54e-05	0.000108	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MDM2—sarcoma	1.5e-05	0.000106	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KIT—sarcoma	1.48e-05	0.000105	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CTNNB1—sarcoma	1.47e-05	0.000104	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KIT—sarcoma	1.46e-05	0.000103	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FOXO1—sarcoma	1.46e-05	0.000103	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PDGFRB—sarcoma	1.45e-05	0.000103	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—HRAS—sarcoma	1.44e-05	0.000102	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—MDM2—sarcoma	1.44e-05	0.000102	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CTNNB1—sarcoma	1.44e-05	0.000102	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PDGFRA—sarcoma	1.43e-05	0.000101	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.43e-05	0.000101	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CTNNB1—sarcoma	1.42e-05	0.0001	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CREB1—sarcoma	1.41e-05	9.98e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—SRC—sarcoma	1.41e-05	9.95e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.39e-05	9.84e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CREB1—sarcoma	1.39e-05	9.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—SRC—sarcoma	1.39e-05	9.81e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—NRAS—sarcoma	1.36e-05	9.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FLT1—sarcoma	1.35e-05	9.54e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—FOXO1—sarcoma	1.35e-05	9.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PDGFRB—sarcoma	1.34e-05	9.48e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—NRAS—sarcoma	1.34e-05	9.43e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PLCG1—sarcoma	1.33e-05	9.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—SRC—sarcoma	1.33e-05	9.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PDGFRA—sarcoma	1.32e-05	9.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—HRAS—sarcoma	1.31e-05	9.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—JUN—sarcoma	1.3e-05	9.21e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—SRC—sarcoma	1.3e-05	9.19e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CTNNB1—sarcoma	1.29e-05	9.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—sarcoma	1.29e-05	9.11e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—SRC—sarcoma	1.28e-05	9.05e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.28e-05	9.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCR4—sarcoma	1.28e-05	9e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—NRAS—sarcoma	1.27e-05	9e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ATF1—sarcoma	1.26e-05	8.9e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.25e-05	8.85e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NRAS—sarcoma	1.25e-05	8.84e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ENO2—sarcoma	1.25e-05	8.84e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HBA1—sarcoma	1.24e-05	8.78e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—sarcoma	1.24e-05	8.73e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NRAS—sarcoma	1.23e-05	8.71e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—sarcoma	1.22e-05	8.59e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.18e-05	8.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—SRC—sarcoma	1.17e-05	8.26e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MDM2—sarcoma	1.17e-05	8.25e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—KRAS—sarcoma	1.17e-05	8.24e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MYC—sarcoma	1.17e-05	8.24e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CREB1—sarcoma	1.16e-05	8.17e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MDM2—sarcoma	1.15e-05	8.13e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—KRAS—sarcoma	1.15e-05	8.12e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MYC—sarcoma	1.15e-05	8.11e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—sarcoma	1.14e-05	8.06e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—NRAS—sarcoma	1.13e-05	7.95e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—sarcoma	1.12e-05	7.94e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—SRC—sarcoma	1.12e-05	7.93e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KIT—sarcoma	1.11e-05	7.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—KRAS—sarcoma	1.1e-05	7.75e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ENO2—sarcoma	1.08e-05	7.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—NRAS—sarcoma	1.08e-05	7.63e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—KRAS—sarcoma	1.08e-05	7.61e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HBA1—sarcoma	1.08e-05	7.61e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PLCG1—sarcoma	1.06e-05	7.5e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KRAS—sarcoma	1.06e-05	7.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CREB1—sarcoma	1.06e-05	7.46e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.05e-05	7.43e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2—sarcoma	1.04e-05	7.38e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2—sarcoma	1.03e-05	7.27e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—KIT—sarcoma	1.03e-05	7.24e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCND1—sarcoma	1.02e-05	7.19e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—JUN—sarcoma	1.02e-05	7.18e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CTNNB1—sarcoma	1.01e-05	7.12e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCND1—sarcoma	1e-05	7.08e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—JUN—sarcoma	1e-05	7.07e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CTNNB1—sarcoma	9.94e-06	7.01e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HRAS—sarcoma	9.92e-06	7.01e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1R—sarcoma	9.9e-06	6.99e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HRAS—sarcoma	9.78e-06	6.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CREB1—sarcoma	9.76e-06	6.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KRAS—sarcoma	9.69e-06	6.84e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ENO2—sarcoma	9.68e-06	6.83e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HBA1—sarcoma	9.62e-06	6.79e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ENO2—sarcoma	9.44e-06	6.67e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FOXO1—sarcoma	9.42e-06	6.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PDGFRB—sarcoma	9.4e-06	6.64e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HBA1—sarcoma	9.39e-06	6.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HRAS—sarcoma	9.33e-06	6.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KRAS—sarcoma	9.31e-06	6.57e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PDGFRA—sarcoma	9.26e-06	6.54e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PLCG1—sarcoma	9.2e-06	6.49e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HRAS—sarcoma	9.16e-06	6.47e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SRC—sarcoma	9.12e-06	6.44e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HRAS—sarcoma	9.03e-06	6.37e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SRC—sarcoma	8.98e-06	6.34e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—sarcoma	8.88e-06	6.27e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NRAS—sarcoma	8.77e-06	6.19e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—sarcoma	8.75e-06	6.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MDM2—sarcoma	8.74e-06	6.17e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NRAS—sarcoma	8.64e-06	6.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2—sarcoma	8.55e-06	6.04e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HRAS—sarcoma	8.24e-06	5.82e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PLCG1—sarcoma	8.21e-06	5.8e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MYC—sarcoma	8.17e-06	5.77e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MDM2—sarcoma	8.07e-06	5.7e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MYC—sarcoma	8.05e-06	5.68e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PLCG1—sarcoma	8.01e-06	5.66e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—sarcoma	7.99e-06	5.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HRAS—sarcoma	7.91e-06	5.58e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—sarcoma	7.87e-06	5.56e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2—sarcoma	7.81e-06	5.52e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KDR—sarcoma	7.79e-06	5.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—JUN—sarcoma	7.6e-06	5.37e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KRAS—sarcoma	7.55e-06	5.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTNNB1—sarcoma	7.54e-06	5.32e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KRAS—sarcoma	7.44e-06	5.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KIT—sarcoma	7.18e-06	5.07e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—NRAS—sarcoma	7.18e-06	5.07e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CTNNB1—sarcoma	6.96e-06	4.92e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CREB1—sarcoma	6.83e-06	4.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—SRC—sarcoma	6.82e-06	4.81e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—sarcoma	6.71e-06	4.74e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—sarcoma	6.61e-06	4.67e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NRAS—sarcoma	6.56e-06	4.63e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HRAS—sarcoma	6.42e-06	4.53e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HRAS—sarcoma	6.32e-06	4.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—SRC—sarcoma	6.29e-06	4.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—KRAS—sarcoma	6.18e-06	4.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NRAS—sarcoma	6.05e-06	4.27e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ENO2—sarcoma	5.82e-06	4.11e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HBA1—sarcoma	5.78e-06	4.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MDM2—sarcoma	5.65e-06	3.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KRAS—sarcoma	5.64e-06	3.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MYC—sarcoma	5.64e-06	3.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HRAS—sarcoma	5.25e-06	3.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—KRAS—sarcoma	5.21e-06	3.68e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2—sarcoma	5.05e-06	3.57e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLCG1—sarcoma	4.94e-06	3.49e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCND1—sarcoma	4.92e-06	3.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—JUN—sarcoma	4.91e-06	3.47e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CTNNB1—sarcoma	4.88e-06	3.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HRAS—sarcoma	4.8e-06	3.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—HRAS—sarcoma	4.43e-06	3.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SRC—sarcoma	4.41e-06	3.11e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—sarcoma	4.29e-06	3.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NRAS—sarcoma	4.24e-06	2.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MYC—sarcoma	3.95e-06	2.79e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KRAS—sarcoma	3.65e-06	2.58e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—sarcoma	3.24e-06	2.29e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HRAS—sarcoma	3.1e-06	2.19e-05	CbGpPWpGaD
